Asymmetry Capital Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Asymmetry Capital Management’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-72,712	Closed	-$3.41M	–	42
2020 Q1	$3.41M	Buy	72,712 +49,689	+216%	+$3.18M	3.73%	11
2019 Q4	$1.68M	Sell	23,023 -24,879	-52%	-$1.51M	3.01%	13
2019 Q3	$2.5M	Sell	47,902 -78,753	-62%	-$4.19M	5.35%	8
2019 Q2	$6.35M	Buy	126,655 +64,094	+102%	+$3.12M	3.44%	11
2019 Q1	$3.25M	Buy	+62,561	New	+$2.88M	5.44%	8

Other funds holding MYOK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Asymmetry Capital Management's MYOK Position: Q2 2020 in Review

Asymmetry Capital Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q2 2020, closing a stake of 72,712 shares — an estimated $3.41M sold.

Asymmetry Capital Management first reported a position in MYOK in Q1 2019 and held it in 5 quarters. The position peaked at $6.35M in Q2 2019. 235 funds tracked by Wall St. Rank hold MYOK as of Q2 2020.

Asymmetry Capital Management reported no remaining MyoKardia, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Asymmetry Capital Management sold 72,712 MyoKardia, Inc. Common Stock shares in Q2 2020, an estimated $3.41M.
Asymmetry Capital Management first reported a position in MyoKardia, Inc. Common Stock in Q1 2019 and held it in 5 quarters.
Asymmetry Capital Management's MyoKardia, Inc. Common Stock position peaked at $6.35M in Q2 2019.
235 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q2 2020.

Based on Asymmetry Capital Management's 13F filing for Q2 2020, filed 6 Aug 2020.